stoxline Quote Chart Rank Option Currency Glossary
  
Enlivex Therapeutics Ltd. (ENLV)
3.79  -0.07 (-1.81%)    03-28 16:00
Open: 3.75
High: 3.9651
Volume: 126,493
  
Pre. Close: 3.86
Low: 3.72
Market Cap: 70(M)
Technical analysis
2024-03-28 4:51:07 PM
Short term     
Mid term     
Targets 6-month :  5.1 1-year :  5.96
Resists First :  4.36 Second :  5.1
Pivot price 3.97
Supports First :  3.38 Second :  2.77
MAs MA(5) :  3.87 MA(20) :  3.8
MA(100) :  2.72 MA(250) :  2.5
MACD MACD :  0.1 Signal :  0.2
%K %D K(14,3) :  52.3 D(3) :  59.2
RSI RSI(14): 53
52-week High :  4.36 Low :  1.2
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ENLV ] has closed above bottom band by 27.7%. Bollinger Bands are 26% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 3.97 - 4 4 - 4.02
Low: 3.67 - 3.7 3.7 - 3.72
Close: 3.75 - 3.8 3.8 - 3.83
Company Description

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2005 and is headquartered in Nes Ziona, Israel.

Headline News

Mon, 25 Mar 2024
Is Enlivex Therapeutics Ltd (ENLV) Stock at the Top of the Biotechnology Industry? - InvestorsObserver

Fri, 22 Mar 2024
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on ... - Yahoo Finance

Sat, 16 Mar 2024
Short Interest in Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Expands By 51.2% - MarketBeat

Tue, 12 Mar 2024
Is Enlivex Therapeutics Ltd (ENLV) Stock at the Top of the Biotechnology Industry? - InvestorsObserver

Thu, 07 Mar 2024
Enlivex Therapeutics Ltd (ENLV) has gained 1.19% Thursday In Premarket Trading - InvestorsObserver

Tue, 05 Mar 2024
Enlivex Therapeutics (NASDAQ:ENLV) Trading Up 6.5% - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 19 (M)
Shares Float 15 (M)
Held by Insiders 11.8 (%)
Held by Institutions 8.9 (%)
Shares Short 227 (K)
Shares Short P.Month 161 (K)
Stock Financials
EPS -1.48
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.08
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -28.2 %
Return on Equity (ttm) -53.3 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.41
Qtrly Earnings Growth 0 %
Operating Cash Flow -23 (M)
Levered Free Cash Flow -16 (M)
Stock Valuations
PE Ratio -2.58
PEG Ratio 0
Price to Book value 1.81
Price to Sales 0
Price to Cash Flow -3.06
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android